Company register
Suiks Biofarma EOOD
- Company No. 204684989
- Single-member limited liability company (EOOD)
- Active
- п.к. 1505, гр. София, р-н Оборище, бул. Ситняково 48, Сердика център…
- First contract in the database: 18 Aug 2026
Follow this company for free An email on a new contract, a new owner, transferred shares or an attachment.
Data from the Commercial Register
Suiks Biofarma EOOD is single-member limited liability company (eood) with its registered office in гр. София, Company No. 204684989. It is managed by Жан and Петр Пипал. It has 1 contract in public procurement worth €4.4m in total.
- Name
- Суикс Биофарма ЕООД
- Company No.
- 204684989
- Legal form
- Single-member limited liability company (EOOD)
- Status
- Active
- Public tenders
- 1 contract · €4.4m
- Registered office and address
- п.к. 1505, гр. София, р-н Оборище, бул. Ситняково 48, Сердика център, ет. 10
- Capital
- 1,02 EUR
- Business activity
- Търговия на едро, внос и износ на лекарства, медицински изделия, хранителни добавки, козметика, бартерни и комисионни сделки, пазарни проучвания и обединяване на общественото мнение, връзки с обществеността и комуникационни дейности, бизнес и други управленски консултантски дейности, рекламни услуги, както и всякакви други търговски дейности, които не са изрично забранени от закона и когато дейностите са предмет на нормативна уредба, след получаване на съответното разрешение.
Source: the Commercial Register and the Register of Non-Profit Legal Entities at the Registry Agency, public enquiry on the current status.
Managers and owners
Management and representation
5- Ж
Zhan Manager ·
France · also in 2 companies - П
Petr Pipal Manager ·
Czechia · also in 5 companies - А
Aleksandar Aleksandrov Marinov Procurator ·
Bulgaria - Б
Boryana Dobreva Hristova Procurator ·
Bulgaria - Д
Diana Radostinova Atanasova Procurator ·
Bulgaria
Owners and partners
3- С
Suiks Biofarma Ag Sole owner ·
Switzerland - Ж
Zhan Beneficial owner ·
France · also in 2 companies - П
Petr Pipal Beneficial owner ·
Czechia · also in 5 companies
The partners' shares are in the “Companies” module. Try it free
History of changes
19 entries- Filed document: current articles of association
- Filed document: annual financial statements for 2025
- Filed document: annual financial statements for 2025
- Filed document: annual financial statements for 2025
- Filed document: annual financial statements for 2024
- Filed document: annual financial statements for 2024
- Filed document: annual financial statements for 2024
- Filed document: annual activity report for 2024
- Filed document: annual financial statements for 2023
- Filed document: annual financial statements for 2023
- Filed document: annual financial statements for 2022
Show the full history (7 dates more)
- Filed document: annual financial statements for 2021
- Filed document: annual financial statements for 2021
- Filed document: current articles of association
- Filed document: annual financial statements for 2020
- Filed document: current articles of association
- Filed document: annual financial statements for 2019
- Filed document: annual financial statements for 2018
- Filed document: annual financial statements for 2017
Source: the Commercial Register, the daily open data of the Registry Agency. Changes in circumstances are from January 2021 onwards, filed documents for the whole period.
Financial indicators
in thousands of euros| Year in thousands of € | 2017 | 2018 | 2019 | 2020 | 2021–2025 |
|---|---|---|---|---|---|
| Accounts filed in the register | 5 of 5 |
Annual statements filed in the Commercial Register: 9 (2017–2025).
The financial data is extracted automatically from the accounts filed in the Commercial Register, for information. Errors are possible – check the original accounts before an important decision.
Related companies
Public tenders
Tenders won
| Subject | Contracting authority | Date | Value |
|---|---|---|---|
| „Доставка на лекарствени продукти за 2026 г., отпускани по реда на Наредба №34 от 25.11.2005 г. за реда за… | Ministerstvo na Zdraveopazvaneto | 18 Aug 2026 | €4.4m |